Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barchiesi

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Infection|August 1, 2014
Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literatureS Mazzocato, E Marchionni, A W Fothergill, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative studyA Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for managementC J Clancy, F Barchiesi, L Falconi DiFrancesco, et al.
Peptides|November 9, 2010
In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida sppE Kamysz, O Simonetti, O Cirioni, et al.
The British Journal of Dermatology|May 15, 2009
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytesO Simonetti, D Arzeni, G Ganzetti, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida sppF Barchiesi, A Giacometti, O Cirioni, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Interactions of posaconazole and flucytosine against Cryptococcus neoformansF Barchiesi, A M Schimizzi, L K Najvar, et al.
Peptides|July 14, 2009
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytesO Simonetti, G Ganzetti, D Arzeni, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosisF Barchiesi, D Arzeni, M S Del Prete, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformansF Barchiesi, A M Schimizzi, F Caselli, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Infection|August 1, 2014
Epidemiology and outcome of systemic infections due to saprochaete capitata: case report and review of the literatureS Mazzocato, E Marchionni, A W Fothergill, et al.
Journal of Clinical Microbiology|September 8, 2005
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative studyA Espinel-Ingroff, F Barchiesi, M Cuenca-Estrella, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 3, 2000
Clinical manifestations and molecular epidemiology of late recurrent candidemia, and implications for managementC J Clancy, F Barchiesi, L Falconi DiFrancesco, et al.
Peptides|November 9, 2010
In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida sppE Kamysz, O Simonetti, O Cirioni, et al.
The British Journal of Dermatology|May 15, 2009
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytesO Simonetti, D Arzeni, G Ganzetti, et al.
Journal of Chemotherapy (Florence, Italy)|December 13, 2007
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida sppF Barchiesi, A Giacometti, O Cirioni, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Interactions of posaconazole and flucytosine against Cryptococcus neoformansF Barchiesi, A M Schimizzi, L K Najvar, et al.
Peptides|July 14, 2009
In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytesO Simonetti, G Ganzetti, D Arzeni, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosisF Barchiesi, D Arzeni, M S Del Prete, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformansF Barchiesi, A M Schimizzi, F Caselli, et al.
Pageof 9